What question did this study set out to answer?

This research aims to evaluate the economic impact of moderate-to-severe rheumatoid arthritis in Spain.

April 3, 2026Journal of Medical Economics0 citationsOpen Access

The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study

LSLucía Silva-Fernández ACAlejandro Balsa Criado RSRaimon Sanmartí

Key Points

This research aims to evaluate the economic impact of moderate-to-severe rheumatoid arthritis in Spain.
Utilized data from the CIARA study.
Analyzed costs related to out-of-pocket expenses and productivity.
Examined the impact of switching to advanced therapies.
Advanced therapies reduced out-of-pocket expenses.
Observed decreased productivity losses.
Higher pharmaceutical costs were not fully offset by these savings.

Abstract

Switching to advanced therapies reduced out-of-pocket expenses and productivity losses. Although this reduction did not offset higher pharmaceutical spending, it may reflect clinical improvements.

AIに質問

Bookmark

View Full Paper